Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
GBD 2023 Breast Cancer Collaborators
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00730-2/abstract?utm_campaign=update-lanonc&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanonc&_hsenc=p2ANqtz-8KE3OYraJU362DkrE0Wqxkznun4xEBctGWFcvcNr7K0aXIL0nFMITgSsMw2o_5jd3h95xlrrzrLbjEkPh-Sy0fo754tQ&_hsmi=409008184&utm_content=408447862&utm_source=hs_email
Mar 2026
Volume 27Number 3p269-392, e123-e169
https://www.thelancet.com/journals/lanonc/issue/vol27no3/PIIS1470-2045(26)X2002-2
Editorial
p269
England's National Cancer Plan: hollow promises?
The Lancet Oncology
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(26)00077-X/fulltext
Radiotherapy for more efficacious novel anticancer drugs: a position paper from the European Society for Radiotherapy and Oncology (ESTRO) focus group on novel systemic therapies and radiotherapy
Antonio Angrisani, MDa angrisani.antonio.4@gmail.com ∙ Youlia Kirova, MDb ∙ Azadeh Abravan, PhDc,d,e ∙ Carlotta Becherini, MDf ∙ Sergi Benavente, MDg ∙ Luis Castelo-Branco, MDh ∙ et al.
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00660-6/abstract?utm_campaign=update-lanonc&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanonc&_hsenc=p2ANqtz-8uMrT19i56eeI_vVv-RRtmOA0ol6mUbKtYW7FH0oyr5BdQ6hy6bHF1xcXhSiXyLnYRG45o4EaN7ZFDkNKfoPpL8gj2Pg&_hsmi=409008184&utm_content=408447862&utm_source=hs_email
20 years of the Stupp protocol: confronting stagnation in glioblastoma therapy
Mustafa Khasrawa mustafa.khasraw@duke.edu ∙ Emma Pristoa ∙ Roger Stupp
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00705-3/abstract?utm_campaign=update-lanonc&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanonc&_hsenc=p2ANqtz-_o37eb9X72to0ofx1yceHDYYPcX7oVdKDZ7QgO7HATQjBMxo_OT0Mc5lIjN-m1WhmYoOwVHfKknBObicfhapbEnHB18w&_hsmi=409008184&utm_content=408447862&utm_source=hs_email
No hay comentarios:
Publicar un comentario